Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Brain Research. Developmental Brain Research|March 8, 2002
Expression of alpha(2)-adrenergic receptor subtypes in prenatal rat spinal cordYi Huang, W Daniel Stamer, Todd L Anthony, et al.
The Journal of Biological Chemistry|July 31, 2020
15-Keto-PGE<sub>2</sub> acts as a biased/partial agonist to terminate PGE<sub>2</sub>-evoked signalingSuzu Endo, Akiko Suganami, Keijo Fukushima, et al.
Life Sciences|January 22, 2003
Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytesAmy C Porter, Samuel P S Svensson, W Daniel Stamer, et al.
FEBS Letters|October 8, 2017
PGE<sub>1</sub> and E<sub>3</sub> show lower efficacies than E<sub>2</sub> to β-catenin-mediated activity as biased ligands of EP4 prostanoid receptorsYumi Araki, Akiko Suganami, Suzu Endo, et al.
Current Eye Research|May 11, 2010
Induction of angiogenic immediate early genes by activation of FP prostanoid receptors in cultured human ciliary smooth muscle cellsAnthony J Hutchinson, Serena C Coons, Chih-Ling Chou, et al.
Pharmacological Reports : PR|March 31, 2021
The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD<sub>2</sub> or PGE<sub>2</sub>Iori Okura, Nanae Hasuoka, Kanaho Senoo, et al.
The Journal of Biological Chemistry|April 20, 2025
Potent activity of prostaglandin J<sub>2</sub> on prostanoid DP receptorsKanaho Senoo, Keijo Fukushima, Hitomi Yamamoto, et al.
European Journal of Pharmacology|April 14, 2019
Short chain fatty acid butyrate uptake reduces expressions of prostanoid EP<sub>4</sub> receptors and their mediation of cyclooxygenase-2 induction in HCA-7 human colon cancer cellsNaoki Kurata, Natsumi Tokashiki, Keijo Fukushima, et al.
Pharmacology Research & Perspectives|November 21, 2018
Cellular density-dependent increases in HIF-1α compete with c-Myc to down-regulate human EP4 receptor promoter activity through Sp-1-binding regionNaofumi Seira, Kazuyuki Yamagata, Keijo Fukushima, et al.
Biological & Pharmaceutical Bulletin|October 3, 2017
Anti-cancer Effects of MW-03, a Novel Indole Compound, by Inducing 15-Hydroxyprostaglandin Dehydrogenase and Cellular Growth Inhibition in the LS174T Human Colon Cancer Cell LineNaofumi Seira, Naoki Yanagisawa, Akiko Suganami, et al.
Pageof 5